Postpartum Dyspareunia Resulting From Vaginal Atrophy

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Vulvovaginal AtrophyDyspareunia Among Puerperal Women
Interventions
DRUG

Estriol 0.1% vaginal cream

Patients with both vulvovaginal atrophy (according to cytologic criteria) and dyspareunia will apply 0.5 ml of the cream (0.5 mg) to the vulvar vestibule once daily for one month and will return for check-up visit. In case both atrophy and dyspareunia will resolve, treatment with the cream will be continued 3 times a week.

Trial Locations (2)

Unknown

Clalit Women's Health Center, Jerusalem

Clalit Women's Health Center, Modiin

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER